Slow Tapering of Semaglutide Maintains Weight Loss: New Study Insights
Personalized Dosing and Digital Programs Key to Long-Term Success
Topline: A recent study highlights the effectiveness of personalized dosing and gradual tapering of semaglutide (Wegovy or Ozempic) in conjunction with a digital weight loss program. This approach achieves significant weight loss and maintains it for up to six months, offering promising implications for both patients and healthcare providers.
Study Detai…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.